Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model

被引:18
作者
Vorpahl, Marc [1 ]
Nakano, Masataka [1 ]
Perkins, Laura E. L. [2 ]
Otsuka, Fumiyuki [1 ]
Jones, Russell [1 ]
Acampado, Eduardo [1 ]
Lane, Jennifer P. [2 ]
Rapoza, Richard [2 ]
Kolodgie, Frank D. [1 ]
Virmani, Renu [1 ]
机构
[1] CVPath Inst Inc, Gaithersburg, MD 20878 USA
[2] Abbott Vasc, Santa Clara, CA USA
关键词
bioresorbable scaffold; everolimus; histology; rabbit; stent; OPTICAL COHERENCE TOMOGRAPHY; CORONARY STENT SYSTEM; CLINICAL FOLLOW-UP; ABSORB; THROMBOSIS; 2ND-GENERATION; RESPONSES; INFLAMMATION; PATHOLOGY; HISTOLOGY;
D O I
10.4244/EIJV10I7A143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: We aimed to investigate a fully bioresorbable poly-l-lactide (PLLA) scaffold to assess vascular remodelling in comparison to a permanent polymeric metal DES. Methods and results: Twenty-five New Zealand white rabbits received an Absorb bioresorbable vascular scaffold (BVS, 1.0 and 1.1) or a CYPHER (R) sirolimus-eluting stent (SES) in the iliac arteries. Twelve arteries were harvested at one month for scanning electron microscopy (SEM) analysis (BVS 1.1). The other implanted (BVS 1.0) arteries (n=32) were explanted at three, six and 36 months for light microscopic analysis. Re-endothelialisation assessed at one month was incomplete in both BVS and SES by SEM, with a trend towards greater coverage in SES (endothelialisation above strut: 32.2% vs. 60.6%, p=0.10). However, light microscopic analysis at later time points revealed greater endothelial coverage in BVS than in SES at 36 months (100.0% vs. 93.3%, p=0.05). Inflammation scores were comparable between arteries implanted with BVS and SES at three months (1.1 vs. 1.1, p=0.99), which decreased over time in the BVS implanted arteries (36 months: 0.0 vs. 0.2, p=0.05). At 36 months, BVS were completely resorbed, and resorption sites were replaced by connective tissue. Conclusions: BVS in the rabbit iliac artery model demonstrated ongoing vascular healing at three and six months, and complete vessel restoration, re-endothelialisation and no to minimal vascular inflammation at 36 months.
引用
收藏
页码:833 / 841
页数:9
相关论文
共 30 条
[11]   Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk [J].
Joner, Michael ;
Finn, Aloke V. ;
Farb, Andrew ;
Mont, Erik K. ;
Kolodgie, Frank D. ;
Ladich, Elena ;
Kutys, Robert ;
Skorija, Kristi ;
Gold, Herman K. ;
Virmani, Renu .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :193-202
[12]   Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings [J].
Kolandaivelu, Kumaran ;
Swaminathan, Rajesh ;
Gibson, William J. ;
Kolachalama, Vijaya B. ;
Nguyen-Ehrenreich, Kim-Lien ;
Giddings, Virginia L. ;
Coleman, Leslie ;
Wong, Gee K. ;
Edelman, Elazer R. .
CIRCULATION, 2011, 123 (13) :1400-1409
[13]   In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia [J].
Kornowski, R ;
Hong, MK ;
Tio, FO ;
Bramwell, O ;
Wu, HS ;
Leon, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (01) :224-230
[14]   The Pathology of Neoatherosclerosis in Human Coronary Implants Bare-Metal and Drug-Eluting Stents [J].
Nakazawa, Gaku ;
Otsuka, Fumiyuki ;
Nakano, Masataka ;
Vorpahl, Marc ;
Yazdani, Saami K. ;
Ladich, Elena ;
Kolodgie, Frank D. ;
Finn, Aloke V. ;
Virmani, Renu .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (11) :1314-1322
[15]   Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents [J].
Nakazawa, Gaku ;
Finn, Aloke V. ;
Vorpahl, Marc ;
Ladich, Elena R. ;
Kolodgie, Frank D. ;
Virmani, Renu .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (04) :390-398
[16]  
Nakazawa Gaku, 2008, Expert Rev Cardiovasc Ther, V6, P1379, DOI 10.1586/14779072.6.10.1379
[17]   Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents Igaki-Tamai Stents [J].
Nishio, Soji ;
Kosuga, Kunihiko ;
Igaki, Keiji ;
Okada, Masaharu ;
Kyo, Eisho ;
Tsuji, Takafumi ;
Takeuchi, Eiji ;
Inuzuka, Yasutaka ;
Takeda, Shinsaku ;
Hata, Tatsuhiko ;
Takeuchi, Yuzo ;
Kawada, Yoshitaka ;
Harita, Takeshi ;
Seki, Junya ;
Akamatsu, Shunji ;
Hasegawa, Shinichi ;
Bruining, Nico ;
Brugaletta, Salvatore ;
de Winter, Sebastiaan ;
Muramatsu, Takashi ;
Onuma, Yoshinobu ;
Serruys, Patrick W. ;
Ikeguchi, Shigeru .
CIRCULATION, 2012, 125 (19) :2343-2352
[18]   Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model An Attempt to Decipher the Human Optical Coherence Tomography Images in the ABSORB Trial [J].
Onuma, Yoshinobu ;
Serruys, Patrick W. ;
Perkins, Laura E. L. ;
Okamura, Takayuki ;
Gonzalo, Nieves ;
Garcia-Garcia, Hector M. ;
Regar, Evelyn ;
Kamberi, Marika ;
Powers, Jennifer C. ;
Rapoza, Richard ;
van Beusekom, Heleen ;
van der Giessen, Willem ;
Virmani, Renu .
CIRCULATION, 2010, 122 (22) :2288-2300
[19]   Bioresorbable Scaffold Technologies [J].
Onuma, Yosinobu ;
Ormiston, John ;
Serruys, Patrick W. .
CIRCULATION JOURNAL, 2011, 75 (03) :509-520
[20]  
Onuma Y, 2010, EUROINTERVENTION, V6, P447, DOI 10.4244/EIJ30V6I4A76